1. Market Research
  2. > Pharmaceutical
  3. > Drug and Medication Market Trends
  4. > Drug and Medication Analysis & Statistics in the United Kingdom, March 2014 (p3)

Drug and Medication Analysis & Statistics in the United Kingdom, March 2014 (p3)

61-90 of about 100 reports

Purchase Reports From Reputable Market Research Publishers

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World, United Kingdom
Analytical Tool - Lung Cancer

Analytical Tool - Lung Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2014". According ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, United States
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

  • Industries : Pathology, Drug and Medication
  • Countries : Germany, United Kingdom
RB in Consumer Health (World)

RB in Consumer Health (World)

  • $ 570
  • Company report
  • January 2014
  • by Euromonitor International

Reckitt Benckiser Plc (RB) is a world leading consumer goods conglomerate and continues its aggressive movement into the consumer health industry. RB has maintained its competitive position as a top 10 ...

  • Industries : Drug and Medication
  • Countries : World, United Kingdom, Asia, China, United States, Europe
UK Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies

UK Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • January 2014
  • by Venture Planning Group

"UK Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies" is a new strategic analysis of major business opportunities emerging in the UK clinical ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Market

2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Market

  • $ 3 950
  • Industry report
  • December 2013
  • by Venture Planning Group

"2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostic Market" is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2014 Opportunities in the UK Drugs of Abuse Testing Market

2014 Opportunities in the UK Drugs of Abuse Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2014 Opportunities in the UK Therapeutic Drug Monitoring (TDM) Market

2014 Opportunities in the UK Therapeutic Drug Monitoring (TDM) Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 247-page report from Venture Planning Group provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2014 Opportunities in the UK Endocrine Function Testing Market

2014 Opportunities in the UK Endocrine Function Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the UK endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2014 Opportunities in the European Drugs of Abuse Testing Market

2014 Opportunities in the European Drugs of Abuse Testing Market

  • $ 4 200
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Germany, United Kingdom, Italy, Spain
Diabetes – KOL Insight and Consensus Outlook Modules

Diabetes – KOL Insight and Consensus Outlook Modules

  • $ 7 495
  • Industry report
  • December 2013
  • by Firstword Pharma

Introduction The medium term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth. Rising levels of obesity and disease prevalence in both ...

  • Industries : Drug and Medication, Pathology
  • Countries : United States, United Kingdom
2014 Analysis of the UK Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Analysis of the UK Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • October 2013
  • by Venture Planning Group

2014 Analysis of the UK Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies is a new strategic analysis of major business opportunities emerging in ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?

Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?

  • $ 645
  • Industry report
  • September 2013
  • by Firstword Pharma

Sales forecasts for Bristol-Myers Squibb and Pfizer's anticoagulant product Eliquis have declined notably in recent months. According to Bloomberg, current consensus estimates suggest 2018 global revenues ...

  • Industries : Drug and Medication
  • Countries : Europe, United Kingdom, United States
Physician Views – How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?

Physician Views – How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?

  • $ 645
  • Industry report
  • September 2013
  • by Firstword Pharma

Scope Sales forecasts for Bristol-Myers Squibb and Pfizer's anticoagulant product Eliquis have declined notably in recent months. According to Bloomberg, current consensus estimates suggest 2018 global ...

  • Industries : Drug and Medication
  • Countries : Europe, United Kingdom, United States
UK Injectables Market Outlook to 2017

UK Injectables Market Outlook to 2017

  • $ 1 200
  • Industry report
  • September 2013
  • by RNCOS

Injectables occupy a considerable prominence in UK irrespective of diminishing growth in the pharmaceutical market for 2-3 years. The advancements in technology up-gradation and investments have provided ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology
  • Countries : United Kingdom
Ear Care in the United Kingdom

Ear Care in the United Kingdom

  • $ 992
  • Industry report
  • July 2013
  • by Euromonitor International

Volume sales of ear care products fell by 1% in 2012, a significantly poorer performance than that seen over the review period. Consumers’ cautious spending continued, and some consumers were less willing ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Emergency Contraception in the United Kingdom

Emergency Contraception in the United Kingdom

  • $ 992
  • Industry report
  • July 2013
  • by Euromonitor International

In 2012, emergency contraception increased by 3% in current value terms, to reach £25 million. After the introduction of OTC emergency contraceptive pills in 2001, growth was initially rapid, as women ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? – both rejected by the FDA

Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? – both rejected by the FDA

  • $ 645
  • Industry report
  • July 2013
  • by Firstword Pharma

Scope of the Report European-based endocrinologists are currently getting to grips with two new products that have been rejected for approval in the US market. Novo Nordisk’s long-acting basal insulin ...

  • Industries : Drug and Medication, Pathology
  • Countries : Europe, United Kingdom, United States
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs

2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

  • $ 6 500
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Germany, United Kingdom, Italy, Spain
2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs

2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the UK endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs

2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 247-page report from Venture Planning Group provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Top Five Global Cardiovascular Drug Companies: Performance, Strategies and Competitive Analysis

Top Five Global Cardiovascular Drug Companies: Performance, Strategies and Competitive Analysis

  • $ 1 980
  • Industry report
  • December 2012
  • by Lucintel

The global cardiovascular drugs industry experienced average growth over the last five years and is expected to reach approximately US $174.8 billion in 2017, growing with a CAGR of 2.9% over the next ...

  • Industries : Drug and Medication
  • Countries : World, United Kingdom, United States, North America
KOL Insight: Hepatitis C: the race for the first interferon-free regimen

KOL Insight: Hepatitis C: the race for the first interferon-free regimen

  • $ 4 995
  • Industry report
  • November 2012
  • by Firstword Pharma

Analyzing the Hepatitis C Market Landscape After more than a decade of limited treatment options, the hepatitis C (HCV) market is on the cusp of a treatment revolution. In 2011, protease inhibitors-Incivek ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom
Pharma and Payers – Building Better Relationships

Pharma and Payers – Building Better Relationships

  • $ 895
  • Industry report
  • September 2012
  • by Firstword Pharma

Changes in the healthcare landscape have put payers (public and private) under mounting pressure to reduce the cost of care, and given them much greater influence over market access to new medicines. ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Future Horizons in the UK Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

Future Horizons in the UK Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

  • $ 5 900
  • Industry report
  • August 2012
  • by Venture Planning Group

Highlights Comprehensive 855-page market segmentation analysis of the UK NAT market.Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Natural Products 2012

Natural Products 2012

  • $ 898
  • Industry report
  • June 2012
  • by Key Note Publications Ltd

Executive Summary This Key Note Market Report analyses the natural products industry in the UK. It calculates that the market is presently worth £750.4m. The market has failed to grow since 2007 and has ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
The 2012 UK Infectious Disease Testing Market

The 2012 UK Infectious Disease Testing Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the UK infectious disease testing market, including:Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
The 2012 UK Molecular Diagnostics Market

The 2012 UK Molecular Diagnostics Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, ...

  • Industries : Drug and Medication, Pathology
  • Countries : United Kingdom
OTC Pharmaceuticals – UK – (2011)

OTC Pharmaceuticals – UK – (2011)

  • $ 599
  • Industry report
  • December 2011
  • by Mintel

OTC Pharmaceuticals in UK by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers analgesics, cough/col/flu, gastro-intestinal, ...

  • Industries : Over-The-Counter Drug, Drug and Medication, Pharmaceutical
  • Countries : United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.